Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta (Q33929808)

30 July 2017

1 reference

title

Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta (English)

1 reference

30 July 2017

1 reference

Hu X

1

1 reference

PubMed ID

10830731

30 July 2017

Zuckerman KS

series ordinal

2

1 reference

PubMed ID

10830731

30 July 2017

language of work or name

1 reference

1 July 2000

1 reference

30 July 2017

1 reference

30 July 2017

38

1 reference

30 July 2017

3-4

1 reference

30 July 2017

235-246

1 reference

Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells

30 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Identification of another member of the transforming growth factor type beta gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Complementary deoxyribonucleic acid cloning of a novel transforming growth factor-beta messenger ribonucleic acid from chick embryo chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Purification and initial characterization of a type beta transforming growth factor from human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Genomic organization, chromosomal localization, and independent expression of human cyclin D genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Cloning of a D-type cyclin from murine erythroleukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

D-type cyclin-dependent kinase activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Cell cycle control in normal and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Animal cell cycles and their control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Control of the yeast cell cycle by the Cdc28 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Regulation of transcription by proteins that control the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Regulation of retinoblastoma protein functions by ectopic expression of human cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

The transcription factor E2F-1 is a downstream target of RB action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Identification of a growth suppression domain within the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

A cell cycle-regulated inhibitor of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Some recent advances in the chemistry and biology of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Transforming growth factor-beta: a bidirectional regulator of hematopoietic cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Transforming growth factor beta inhibits the action of stem cell factor on mouse and human hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

Inhibitory action of transforming growth factor-beta on induction of differentiation of myeloid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009087015

10.3109/10428190009087015

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10830731